A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Trial to Assess the Analgesic Efficacy and Safety of a New Analgesic Compared to Placebo in Subjects With Painful Diabetic Peripheral Neuropathy.
Phase of Trial: Phase II
Latest Information Update: 29 Apr 2013
At a glance
- Drugs GRT 3983Y (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 13 May 2011 Status changed from active, no longer recruiting to discontinued.
- 26 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Feb 2010 New trial record